Abstract
The development of effective vaccines is a critical step in controlling infectious diseases, and the integration of bioinformatics and artificial intelligence (AI) has revolutionized this process. Bioinformatics tools help in the identification of potential vaccine targets, while AI-driven approaches enhance the design and optimization of vaccine candidates. This article explores how bioinformatics and AI are being utilized in vaccine development, from pathogen genomics and immune profiling to the design of vaccine candidates and prediction of immune responses. We also discuss the challenges and future directions of incorporating these technologies in vaccine research and development.
All articles published in the American Journal of Bioinformatics (AJB) are licensed under the Creative Commons Attribution 4.0 International License (CC BY 4.0). Under this license, authors retain full copyright of their work and grant permission to anyone to:
-
Share — copy and redistribute the material in any medium or format
-
Adapt — remix, transform, and build upon the material for any purpose, even commercially
Conditions:
-
Attribution: Appropriate credit must be given to the original author(s) and the source, a link to the license must be provided, and any changes made must be indicated.
-
No additional restrictions: You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
This open-access license ensures that scholarly work published in AJB is freely accessible and usable, promoting knowledge dissemination and academic collaboration worldw